Fennec Pharmaceuticals (FENC) Amortizatization of Intangibles (2021 - 2025)
Fennec Pharmaceuticals (FENC) posted Amortizatization of Intangibles of $27000.0 for Q4 2025, up 125.0% on a QoQ basis from $12000.0 in Q3 2025, and down 63.51% year-over-year from $74000.0 in Q4 2024.
Fennec Pharmaceuticals (FENC) Amortizatization of Intangibles (2021 - 2025) Analysis & Trends
Fennec Pharmaceuticals' Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $27000.0 for Q4 2025.
- Quarterly Amortizatization of Intangibles fell 63.51% year-over-year to $27000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $65000.0 (down 52.9% YoY) and the FY2025 annual result came in at $65000.0, down 52.9% from the prior year.
- Amortizatization of Intangibles was $27000.0 for Q4 2025 at Fennec Pharmaceuticals, up from $12000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $74000.0 in Q4 2024 and bottomed at $1000.0 in Q4 2021.
- A 5-year average of $17937.5 and a median of $15000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2023 — Amortizatization of Intangibles jumped 1900.0% — and 2025, when it sank 63.51%.
- Fennec Pharmaceuticals' Amortizatization of Intangibles stood at $1000.0 in 2021, then jumped by 1400.0% to $15000.0 in 2022, then changed by 0.0% to $15000.0 in 2023, then surged by 393.33% to $74000.0 in 2024, then sank by 63.51% to $27000.0 in 2025.
- Business Quant data shows FENC's Amortizatization of Intangibles at $27000.0 in Q4 2025, $12000.0 in Q3 2025, and $13000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 3.22 Mn |
| 10 | Fennec Pharmaceuticals | 287.77 Mn | 250.98 Mn | 12.01 Mn | 27,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27,000.00 |
| Dec 31, 2025 | 27,000.00 |
| Sep 30, 2025 | 12,000.00 |
| Sep 30, 2025 | 12,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Dec 31, 2024 | 74,000.00 |
| Dec 31, 2024 | 74,000.00 |
| Sep 30, 2024 | 21,000.00 |
| Sep 30, 2024 | 21,000.00 |
| Jun 30, 2024 | 27,000.00 |
| Jun 30, 2024 | 27,000.00 |
| Mar 31, 2024 | 16,000.00 |
| Mar 31, 2024 | 16,000.00 |
| Dec 31, 2023 | 15,000.00 |
| Dec 31, 2023 | 15,000.00 |
| Sep 30, 2023 | 19,000.00 |
| Sep 30, 2023 | 19,000.00 |